Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 3, 117
- https://doi.org/10.3389/fonc.2013.00117
Abstract
Gastrointestinal stromal tumors (GISTs) in adults are generally driven by somatic gain-of-function mutations in KIT or PDGFRA, and biological therapies targeted to these receptor tyrosine kinases comprise part of the treatment regimen for metastatic and inoperable GISTs. A minority (10–15%) of GISTs in adults, along with ∼85% of pediatric GISTs, lacks oncogenic mutations in KIT and PDGFRA. Not surprisingly these wild type (WT) GISTs respond poorly to kinase inhibitor therapy. A subset of WT GISTs shares a set of distinguishing clinical and pathological features, and a flurry of recent reports has convincingly demonstrated shared molecular characteristics. These GISTs have a distinct transcriptional profile including over-expression of the insulin-like growth factor-1 receptor, and exhibit deficiency in the succinate dehydrogenase (SDH) enzyme complex. The latter is often but not always linked to bi-allelic inactivation of SDH subunit genes, particularly SDHA. This review will summarize the molecular, pathological, and clinical connections that link this group of SDH-deficient neoplasms, and offer a view toward understanding the underlying biology of the disease and the therapeutic challenges implicit to this biology.Keywords
This publication has 139 references indexed in Scilit:
- Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinibCancer Chemotherapy and Pharmacology, 2011
- SDHB immunohistochemistry: a useful tool in the diagnosis of Carney–Stratakis and Carney triad gastrointestinal stromal tumorsLaboratory Investigation, 2010
- Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumorsCancer, 2010
- Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)European Journal Of Cancer, 2010
- Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplificationInternational Journal of Cancer, 2010
- Germline mutations in TMEM127 confer susceptibility to pheochromocytomaNature Genetics, 2010
- High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumorsGenes, Chromosomes and Cancer, 2009
- Genetic aberrations of gastrointestinal stromal tumorsCancer, 2008
- Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumorsGenes, Chromosomes and Cancer, 2008
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003